Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157860503> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2157860503 endingPage "3527" @default.
- W2157860503 startingPage "3513" @default.
- W2157860503 abstract "Galectins form a family of carbohydrate-binding proteins defined by their affinity for beta-galactosides containing glycoconjugates. The carbohydrate recognition domain (CRD) is responsible for the specificity of galectins for saccharides. This binding may result in modulated cell proliferation, cell death and cell migration, three processes that are intimately involved in cancer initiation and progression. Galectins can also display protein-protein types of interactions with their binding partners. Certain galectins directly involved in cancer progression seem to be promising targets for the development of novel therapeutic strategies to combat cancer. Indeed, migrating cancer cells resistant to apoptosis still constitute the principal target for the cytotoxic drugs used to treat cancer patients. Reducing the levels of migration in apoptosis-resistant cancer cells can restore certain levels of sensitivity to apoptosis (and so to pro-apoptotic drugs) in restricted-migration cancer cells. Anti-galectin agents can restrict the levels of migration of several types of cancer cell and should therefore be used in association with cytotoxic drugs to combat metastatic cancer. We provide experimental proof in support of this concept. While the present review focuses on various experimental strategies to impair cancer progression by targeting certain types of galectins, it pays particular attention to glioblastomas, which constitute the ultimate level of malignancy in primary brain tumors. Glioblastomas form the most common type of malignant brain tumor in children and adults, and no glioblastoma patient has been cured to date." @default.
- W2157860503 created "2016-06-24" @default.
- W2157860503 creator A5033613763 @default.
- W2157860503 creator A5035597978 @default.
- W2157860503 creator A5050210411 @default.
- W2157860503 creator A5050607285 @default.
- W2157860503 creator A5053342008 @default.
- W2157860503 creator A5061116957 @default.
- W2157860503 creator A5088475390 @default.
- W2157860503 date "2006-12-01" @default.
- W2157860503 modified "2023-10-04" @default.
- W2157860503 title "Anti-Galectin Compounds as Potential Anti-Cancer Drugs" @default.
- W2157860503 doi "https://doi.org/10.2174/092986706779026219" @default.
- W2157860503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17168720" @default.
- W2157860503 hasPublicationYear "2006" @default.
- W2157860503 type Work @default.
- W2157860503 sameAs 2157860503 @default.
- W2157860503 citedByCount "98" @default.
- W2157860503 countsByYear W21578605032012 @default.
- W2157860503 countsByYear W21578605032013 @default.
- W2157860503 countsByYear W21578605032014 @default.
- W2157860503 countsByYear W21578605032015 @default.
- W2157860503 countsByYear W21578605032016 @default.
- W2157860503 countsByYear W21578605032017 @default.
- W2157860503 countsByYear W21578605032018 @default.
- W2157860503 countsByYear W21578605032019 @default.
- W2157860503 countsByYear W21578605032020 @default.
- W2157860503 countsByYear W21578605032021 @default.
- W2157860503 countsByYear W21578605032022 @default.
- W2157860503 countsByYear W21578605032023 @default.
- W2157860503 crossrefType "journal-article" @default.
- W2157860503 hasAuthorship W2157860503A5033613763 @default.
- W2157860503 hasAuthorship W2157860503A5035597978 @default.
- W2157860503 hasAuthorship W2157860503A5050210411 @default.
- W2157860503 hasAuthorship W2157860503A5050607285 @default.
- W2157860503 hasAuthorship W2157860503A5053342008 @default.
- W2157860503 hasAuthorship W2157860503A5061116957 @default.
- W2157860503 hasAuthorship W2157860503A5088475390 @default.
- W2157860503 hasConcept C121608353 @default.
- W2157860503 hasConcept C13426554 @default.
- W2157860503 hasConcept C154317977 @default.
- W2157860503 hasConcept C156293190 @default.
- W2157860503 hasConcept C190283241 @default.
- W2157860503 hasConcept C202751555 @default.
- W2157860503 hasConcept C203014093 @default.
- W2157860503 hasConcept C2776336362 @default.
- W2157860503 hasConcept C502942594 @default.
- W2157860503 hasConcept C54355233 @default.
- W2157860503 hasConcept C55493867 @default.
- W2157860503 hasConcept C86803240 @default.
- W2157860503 hasConcept C96232424 @default.
- W2157860503 hasConceptScore W2157860503C121608353 @default.
- W2157860503 hasConceptScore W2157860503C13426554 @default.
- W2157860503 hasConceptScore W2157860503C154317977 @default.
- W2157860503 hasConceptScore W2157860503C156293190 @default.
- W2157860503 hasConceptScore W2157860503C190283241 @default.
- W2157860503 hasConceptScore W2157860503C202751555 @default.
- W2157860503 hasConceptScore W2157860503C203014093 @default.
- W2157860503 hasConceptScore W2157860503C2776336362 @default.
- W2157860503 hasConceptScore W2157860503C502942594 @default.
- W2157860503 hasConceptScore W2157860503C54355233 @default.
- W2157860503 hasConceptScore W2157860503C55493867 @default.
- W2157860503 hasConceptScore W2157860503C86803240 @default.
- W2157860503 hasConceptScore W2157860503C96232424 @default.
- W2157860503 hasIssue "29" @default.
- W2157860503 hasLocation W21578605031 @default.
- W2157860503 hasLocation W21578605032 @default.
- W2157860503 hasOpenAccess W2157860503 @default.
- W2157860503 hasPrimaryLocation W21578605031 @default.
- W2157860503 hasRelatedWork W2001413622 @default.
- W2157860503 hasRelatedWork W2079070671 @default.
- W2157860503 hasRelatedWork W2157860503 @default.
- W2157860503 hasRelatedWork W2175018905 @default.
- W2157860503 hasRelatedWork W2386605958 @default.
- W2157860503 hasRelatedWork W2501960686 @default.
- W2157860503 hasRelatedWork W2506475006 @default.
- W2157860503 hasRelatedWork W2899741460 @default.
- W2157860503 hasRelatedWork W3012168770 @default.
- W2157860503 hasRelatedWork W4309579423 @default.
- W2157860503 hasVolume "13" @default.
- W2157860503 isParatext "false" @default.
- W2157860503 isRetracted "false" @default.
- W2157860503 magId "2157860503" @default.
- W2157860503 workType "article" @default.